Navigation Links
World Health Organization releases latest Dengue Bulletin
Date:6/17/2011

of the disease in the city of 3.5 million persons. The authors found that 32.9% of the persons surveyed experienced the disease, of which the major symptoms were fever, chills, headache, joint swelling and itching. The prevalence was higher in slum neighbourhoods (where more than 40% of the population lived) than in ones with bungalows and apartments. The municipal authority officially reported 60 777 cases within the city limits. However, the survey found that only 23% of cases sought treatment within public facilities compared with 68% from private facilities and 9% that sought no treatment. Thus, they conclude that the official reports may substantially understate the total burden of illness.

The sixth paper, Prevalence of various symptoms and cost of treatment during chikungunya epidemic in Ahmedabad, Gujarat, India, by Dileep Mavalankar and co-authors, estimates the economic cost of the 2006 outbreak of the viral disease with further analyses of the survey data provided in the previous paper of Puwar et al. The sixth paper notes that the disease affected primarily working-age adults, with the highest number of cases occurring in the age decade of 30󈞓. For this neglected disease in this one city, the authors estimated that the immediate cost of the outbreak due to lost wages and treatment costs was approximately US$ 1.7 million based only on officially reported cases. Assuming that the actual number of cases may be 5 to 10 times the reported number, the actual economic cost of the chikungunya outbreak in Ahmedabad may have been US$ 8.6 to US$ 17.3 million, respectively.

India is also the setting of the seventh paper, A private hospital-based study assessing knowledge, attitude, practice and cost associated with dengue illness in Surat, India, by Ami T. Bhavsar and colleagues. As many private facilities and their patients are often reluctant to share their data with researchers, most studies of disease cost and burden are set in public f
'/>"/>

Contact: Susan Chaityn Lebovits
lebovits@brandeis.edu
781-736-4027
Brandeis University
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. NASA satellite gallery shows Chilean volcano plume moving around the world
2. First-of-its-kind fluorescence map offers a new view of the worlds land plants
3. ACSM: Weight loss success in a 3-D virtual world
4. 1 world, 1 sound
5. Void in leadership on world water crisis cited by 20 former heads of government
6. Tiny bubbles signal severe impacts to coral reefs worldwide
7. World-wide assessment determines differences in cultures
8. First analysis of invasive plant impacts worldwide
9. The Pantanal: A book on the ecology of the largest contiguous wetland in the world
10. The True Shrikes (Laniidae) of the World by E.N. Panov
11. Worm discovery could help 1 billion people worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... scientific basis for eventual treatment, neurology researchers have shown ... protein that helps keep brain activity in balance. The ... an underlying reason for seizures and memory defects experienced ... (TBI). , "A traumatic brain injury occurs to someone ...
... an immune response against HIV, research funded by the Wellcome ... in the US has found that bigger is not necessarily ... a profound impact on the development of a vaccine against ... bigger the immune response, the more effective it will be ...
... Scientists have discovered that autoimmunity can be triggered in the ... cells fail to recognize just one of the body's thousands ... view that autoimmunity can start in this cradle of the ... diseases emerge, such as the pancreas in the case of ...
Cached Biology News:How brain injury leads to seizures, memory problems 2Quality not quantity important for immune response to HIV 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... Admin system was developed to solve many of the complex logistical and ... studies that involve multiple clinical sites and/or remote data coordination centers. , ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... ... in Personalized Medicine, recently hosted their 2015 bi-annual Pain Management Medical Advisory Board ... met with Proove Biosciences’ executive Research and Development team to discuss new clinical ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... ) has announced the addition of the ... offering. Biotechnology for the Non-Biotechnologist, ideal ... basic theory, principles, techniques and potential of biotechnology. ... to understand the basic theory, principles, techniques, and ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... For many ... a user had a high-end machine such as a Varian Cary 4000-7000, a Perkin ... widespread was this design that even NIST used them for their SRM-2031 series going ...
Breaking Biology Technology:ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 3Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3
... , , SOUTH SAN FRANCISCO, ... today announced that 320 evaluable events (patient deaths) have occurred in its ... is being conducted in accordance with a Special Protocol Assessment (SPA) with ... of small cell lung cancer (SCLC). , , ...
... WOBURN, Mass., Sept. 15 BioVex Inc, a biotechnology ... infectious disease, announced today that the U.S. Food and Drug Administration ... clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line ... neck. , , The study is the ...
... , SAN DIEGO, Sept. 15 ... with China, today announced a strategic partnership agreement with Guangzhou ... HUYA has established a series of strategic partnerships with Chinese ... portfolio of novel biopharmaceutical products. The agreement with GIBH provides ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 4HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 2HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 3
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
WIF-1 (N-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: